Summary

Global Mobile Cardiac Telemetry Systems Market is valued approximately USD 1047.72 million in 2023 and is anticipated to grow with a healthy growth rate of more than 12.72% over the forecast period 2024-2032. Mobile Cardiac Telemetry (MCT) systems are wearable devices that continuously monitor a person's heart activity for extended periods, detecting irregular rhythms and other cardiac events. These small devices transmit data wirelessly to healthcare providers, who analyze the information for abnormalities. MCT systems are crucial for diagnosing and managing heart conditions like atrial fibrillation, offering real-time monitoring and timely interventions for patients. The growing integration with healthcare ecosystems is a key trend that is supporting the growth of the Global Mobile Cardiac Telemetry Systems Market at a substantial rate. MCT systems are increasingly being integrated with broader healthcare ecosystems, including electronic health records (EHRs), telehealth platforms, and wearable technologies. This integration allows for seamless data sharing, comprehensive patient management, and collaborative decision-making among healthcare providers.

The rising incidence of cardiovascular disorders and related mortality rates has heightened awareness regarding the advantages offered by Mobile Cardiac Telemetry (MCT) devices, which is a major driving factor for the growth of the Global Mobile Cardiac Telemetry Systems Market. The growing adoption of remote patient monitoring solutions across healthcare systems worldwide, driven by factors such as telemedicine expansion, patient preference for home-based care, and the need to reduce hospital readmissions, fuels the demand for mobile cardiac telemetry systems. Additionally, the demographic shift towards an aging population amplifies the demand for long-term monitoring solutions capable of detecting irregular heart rhythms and other cardiac abnormalities. Technological advancements in wearable sensor technology, wireless connectivity, and data analytics further enhance the accuracy and efficacy of these systems, making them invaluable for real-time monitoring and diagnosis. However, the lack of professional training & education, along with stringent regulatory policies and quality control standards are expected to hinder market expansion over the 2024–2032 projection period.

The key regions considered for the global Mobile Cardiac Telemetry Systems Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. In 2023, North America was the dominating regional market in terms of revenue. The growth of the market can be attributed to several factors including the growing elderly population, higher prevalence of cardiac disorders, and increased healthcare spending. Additionally, the presence of major service providers offering improved healthcare solutions is anticipated to drive market expansion during the forecast period. Whereas, the market in Asia Pacific is expected to grow at the fastest rate over the forecast period. Factors such as dietary habits and the growing adoption of sedentary lifestyles leading to physical inactivity are contributing to the rising incidence of cardiovascular diseases in the region.

Major market player included in this report are:
BioTelemetry, Inc.
ScottCare
Biotricity Inc.
Welch Allyn
Applied Cardiac Systems Inc.
Medicomp Inc.
Preventice Solutions
Telerhythmics LLC
Zoll Medical Corporation
iRhythm Technologies, Inc.


The detailed segments and sub-segment of the market are explained below:

By Application
Lead based
Patch Based

By End-use
Hospitals
Cardiac centers
Others


By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Middle East & Africa
Saudi Arabia
South Africa
RoMEA

Years considered for the study are as follows:
Historical year – 2022
Base year – 2023
Forecast period – 2024 to 2032

Key Takeaways:
Market Estimates & Forecast for 10 years from 2022 to 2032.
Annualized revenues and regional level analysis for each market segment.
Detailed analysis of geographical landscape with Country level analysis of major regions.
Competitive landscape with information on major players in the market.
Analysis of key business strategies and recommendations on future market approach.
Analysis of competitive structure of the market.
Demand side and supply side analysis of the market

ページTOPに戻る

Table of Contents

Chapter 1. Global Mobile Cardiac Telemetry Systems Market Definition and Research Assumptions
1.1. Research Objective
1.2. Market Definition
1.3. Research Assumptions
1.3.1. Inclusion & Exclusion
1.3.2. Limitations
1.3.3. Supply Side Analysis
1.3.3.1. Availability
1.3.3.2. Infrastructure
1.3.3.3. Regulatory Environment
1.3.3.4. Market Competition
1.3.3.5. Economic Viability (Consumer’s Perspective)
1.3.4. Demand Side Analysis
1.3.4.1. Regulatory frameworks
1.3.4.2. Technological Advancements
1.3.4.3. Environmental Considerations
1.3.4.4. Consumer Awareness & Acceptance
1.4. Estimation Methodology
1.5. Years Considered for the Study
1.6. Currency Conversion Rates

Chapter 2. Executive Summary
2.1. Global Mobile Cardiac Telemetry Systems Market Size & Forecast (2022- 2032)
2.2. Regional Summary
2.3. Segmental Summary
2.3.1. By Application
2.3.2. By End-use
2.4. Key Trends
2.5. Recession Impact
2.6. Analyst Recommendation & Conclusion
Chapter 3. Global Mobile Cardiac Telemetry Systems Market Dynamics
3.1. Market Drivers
3.2. Market Challenges
3.3. Market Opportunities
Chapter 4. Global Mobile Cardiac Telemetry Systems Market: Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.1.6. Futuristic Approach to Porter’s 5 Force Model
4.1.7. Porter’s 5 Force Impact Analysis
4.2. PESTEL Analysis
4.2.1. Political
4.2.2. Economic
4.2.3. Social
4.2.4. Technological
4.2.5. Environmental
4.2.6. Legal
4.3. Top investment opportunity
4.4. Top winning strategies
4.5. Disruptive Trends
4.6. Industry Expert Perspective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Global Mobile Cardiac Telemetry Systems Market Size & Forecasts by Application 2022-2032
5.1. Lead based
5.2. Patch Based
Chapter 6. Global Mobile Cardiac Telemetry Systems Market Size & Forecasts by End-use 2022-2032
6.1. Hospitals
6.2. Cardiac centers
6.3. Others
Chapter 7. Global Mobile Cardiac Telemetry Systems Market Size & Forecasts by Region 2022-2032
7.1. North America Mobile Cardiac Telemetry Systems Market
7.1.1. U.S. Mobile Cardiac Telemetry Systems Market
7.1.1.1. Application breakdown size & forecasts, 2022-2032
7.1.1.2. End-use breakdown size & forecasts, 2022-2032
7.1.2. Canada Mobile Cardiac Telemetry Systems Market
7.2. Europe Mobile Cardiac Telemetry Systems Market
7.2.1. U.K. Mobile Cardiac Telemetry Systems Market
7.2.2. Germany Mobile Cardiac Telemetry Systems Market
7.2.3. France Mobile Cardiac Telemetry Systems Market
7.2.4. Spain Mobile Cardiac Telemetry Systems Market
7.2.5. Italy Mobile Cardiac Telemetry Systems Market
7.2.6. Rest of Europe Mobile Cardiac Telemetry Systems Market
7.3. Asia-Pacific Mobile Cardiac Telemetry Systems Market
7.3.1. China Mobile Cardiac Telemetry Systems Market
7.3.2. India Mobile Cardiac Telemetry Systems Market
7.3.3. Japan Mobile Cardiac Telemetry Systems Market
7.3.4. Australia Mobile Cardiac Telemetry Systems Market
7.3.5. South Korea Mobile Cardiac Telemetry Systems Market
7.3.6. Rest of Asia Pacific Mobile Cardiac Telemetry Systems Market
7.4. Latin America Mobile Cardiac Telemetry Systems Market
7.4.1. Brazil Mobile Cardiac Telemetry Systems Market
7.4.2. Mexico Mobile Cardiac Telemetry Systems Market
7.4.3. Rest of Latin America Mobile Cardiac Telemetry Systems Market
7.5. Middle East & Africa Mobile Cardiac Telemetry Systems Market
7.5.1. Saudi Arabia Mobile Cardiac Telemetry Systems Market
7.5.2. South Africa Mobile Cardiac Telemetry Systems Market
7.5.3. Rest of Middle East & Africa Mobile Cardiac Telemetry Systems Market
Chapter 8. Competitive Intelligence
8.1. Key Company SWOT Analysis
8.1.1. Company 1
8.1.2. Company 2
8.1.3. Company 3
8.2. Top Market Strategies
8.3. Company Profiles
8.3.1. BioTelemetry, Inc.
8.3.1.1. Key Information
8.3.1.2. Overview
8.3.1.3. Financial (Subject to Data Availability)
8.3.1.4. Product Summary
8.3.1.5. Market Strategies
8.3.2. ScottCare
8.3.3. Biotricity Inc.
8.3.4. Welch Allyn
8.3.5. Applied Cardiac Systems Inc.
8.3.6. Medicomp Inc.
8.3.7. Preventice Solutions
8.3.8. Telerhythmics LLC
8.3.9. Zoll Medical Corporation
8.3.10. iRhythm Technologies, Inc.
Chapter 9. Research Process
9.1. Research Process
9.1.1. Data Mining
9.1.2. Analysis
9.1.3. Market Estimation
9.1.4. Validation
9.1.5. Publishing
9.2. Research Attributes